Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

• Anastasia Anthi,
• Eleni Stagaki,
• Loukianos Rallidis,
• Dimitrios Konstantonis,
• Maria-Eleftheria Evangelopoulos,
• Konstantinos Voumvourakis,
• Apostolos Armaganidis,
• Stylianos E. Orfanos

Affiliations

Anastasia Anthi

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece

Eleni Stagaki

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece

Loukianos Rallidis

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece

Dimitrios Konstantonis

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece

Maria-Eleftheria Evangelopoulos

Demyelinating Diseases Unit, Dept of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece

Konstantinos Voumvourakis

2nd Dept of Neurology, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece

Apostolos Armaganidis

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece

Stylianos E. Orfanos

Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece